BR0313546A - Uso de acetato de anacortave para a proteção de acuidade visual em pacientes com degeneração macular relacionada com a idade - Google Patents

Uso de acetato de anacortave para a proteção de acuidade visual em pacientes com degeneração macular relacionada com a idade

Info

Publication number
BR0313546A
BR0313546A BR0313546-2A BR0313546A BR0313546A BR 0313546 A BR0313546 A BR 0313546A BR 0313546 A BR0313546 A BR 0313546A BR 0313546 A BR0313546 A BR 0313546A
Authority
BR
Brazil
Prior art keywords
patients
age
macular degeneration
visual acuity
related macular
Prior art date
Application number
BR0313546-2A
Other languages
English (en)
Portuguese (pt)
Inventor
Janice A Jerdan
Patricia Zilliox
Stella M Robertson
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of BR0313546A publication Critical patent/BR0313546A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
BR0313546-2A 2002-08-05 2003-06-26 Uso de acetato de anacortave para a proteção de acuidade visual em pacientes com degeneração macular relacionada com a idade BR0313546A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40122002P 2002-08-05 2002-08-05
PCT/US2003/020154 WO2004012742A1 (en) 2002-08-05 2003-06-26 Use of anecortave acetate for the protection of visual acuity in patients with age related macular degeneration

Publications (1)

Publication Number Publication Date
BR0313546A true BR0313546A (pt) 2005-07-12

Family

ID=31495940

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0313546-2A BR0313546A (pt) 2002-08-05 2003-06-26 Uso de acetato de anacortave para a proteção de acuidade visual em pacientes com degeneração macular relacionada com a idade

Country Status (17)

Country Link
US (2) US20040127472A1 (https=)
EP (1) EP1539182A4 (https=)
JP (1) JP2005535691A (https=)
KR (1) KR20050026510A (https=)
CN (1) CN1674913A (https=)
AR (1) AR040599A1 (https=)
AU (1) AU2003281817A1 (https=)
BR (1) BR0313546A (https=)
CA (1) CA2494211A1 (https=)
DE (1) DE03742226T1 (https=)
ES (1) ES2244361T1 (https=)
MX (1) MXPA05000773A (https=)
PL (1) PL375024A1 (https=)
RU (1) RU2322239C2 (https=)
TW (1) TW200410699A (https=)
WO (1) WO2004012742A1 (https=)
ZA (1) ZA200500731B (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040127472A1 (en) * 2002-08-05 2004-07-01 Jerdan Janice A. Use of anecortave acetate for the protection of visual acuity in patients with age related macular degeneration
MXPA05008396A (es) * 2003-02-20 2006-03-30 Alcon Inc Formulaciones de glucocorticoides para tratar angiogenesis ocular patologica.
AU2004249256A1 (en) * 2003-06-20 2004-12-29 Alcon, Inc. Treatment of AMD with combination of ingredients
CA2539023A1 (en) * 2003-09-23 2005-04-14 Alcon Inc. Triamcinolone acetonide and anecortave acetate formulations for injection
US7257366B2 (en) * 2003-11-26 2007-08-14 Osmosis Llc System and method for teaching a new language
WO2005110374A1 (en) * 2004-04-30 2005-11-24 Allergan, Inc. Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component
US20060182783A1 (en) * 2004-04-30 2006-08-17 Allergan, Inc. Sustained release intraocular drug delivery systems
US20070059336A1 (en) * 2004-04-30 2007-03-15 Allergan, Inc. Anti-angiogenic sustained release intraocular implants and related methods
US7261529B2 (en) * 2005-09-07 2007-08-28 Southwest Research Institute Apparatus for preparing biodegradable microparticle formulations containing pharmaceutically active agents
US7758778B2 (en) * 2005-09-07 2010-07-20 Southwest Research Institute Methods for preparing biodegradable microparticle formulations containing pharmaceutically active agents
US9693967B2 (en) * 2005-09-07 2017-07-04 Southwest Research Institute Biodegradable microparticle pharmaceutical formulations exhibiting improved released rates
US20070134244A1 (en) * 2005-10-14 2007-06-14 Alcon, Inc. Combination treatment for pathologic ocular angiogenesis
MX2009006146A (es) * 2006-12-18 2009-06-19 Alcon Res Ltd Dispositivos y metodos para la administracion de farmacos oftalmicos.
CN101759741B (zh) * 2008-11-06 2013-01-09 天津金耀集团有限公司 一种化合物及其在制备治疗血管新生的药物中的应用
CN101923856B (zh) 2009-06-12 2012-06-06 华为技术有限公司 语音识别训练处理、控制方法及装置
US20150037422A1 (en) * 2012-02-22 2015-02-05 Trustees Of Tufts College Compositions and methods for ocular delivery of a therapeutic agent
RU2489146C1 (ru) * 2012-07-11 2013-08-10 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт глазных болезней" Российской академии медицинских наук (ФГБУ "НИИГБ" РАМН) Способ лечения "сухой" формы возрастной макулярной дегенерации

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4876250A (en) * 1988-10-31 1989-10-24 Alcon Laboratories, Inc. Methods for controlling ocular hypertension with angiostatic steroids
RU2051651C1 (ru) * 1988-07-07 1996-01-10 Институт химии поверхности АН Украины Основа для глазных капель
US5371078A (en) * 1988-10-31 1994-12-06 Alcon Laboratories, Inc. Angiostatic steroids and methods and compositions for controlling ocular hypertension
US5770592A (en) * 1991-11-22 1998-06-23 Alcon Laboratories, Inc. Prevention and treatment of ocular neovascularization using angiostatic steroids
US5679666A (en) * 1991-11-22 1997-10-21 Alcon Laboratories, Inc. Prevention and treatment of ocular neovascularization by treatment with angiostatic steroids
ATE283013T1 (de) * 1999-10-21 2004-12-15 Alcon Inc Medikamentenzuführvorrichtung
US6416777B1 (en) * 1999-10-21 2002-07-09 Alcon Universal Ltd. Ophthalmic drug delivery device
US20040127472A1 (en) * 2002-08-05 2004-07-01 Jerdan Janice A. Use of anecortave acetate for the protection of visual acuity in patients with age related macular degeneration
US20070134244A1 (en) * 2005-10-14 2007-06-14 Alcon, Inc. Combination treatment for pathologic ocular angiogenesis

Also Published As

Publication number Publication date
AR040599A1 (es) 2005-04-13
ZA200500731B (en) 2006-08-30
RU2005106234A (ru) 2005-08-10
KR20050026510A (ko) 2005-03-15
US20060166956A1 (en) 2006-07-27
AU2003281817A1 (en) 2004-02-23
MXPA05000773A (es) 2005-04-19
CN1674913A (zh) 2005-09-28
TW200410699A (en) 2004-07-01
WO2004012742A1 (en) 2004-02-12
US20040127472A1 (en) 2004-07-01
PL375024A1 (en) 2005-11-14
DE03742226T1 (de) 2006-03-09
ES2244361T1 (es) 2005-12-16
JP2005535691A (ja) 2005-11-24
CA2494211A1 (en) 2004-02-12
EP1539182A1 (en) 2005-06-15
EP1539182A4 (en) 2010-01-20
RU2322239C2 (ru) 2008-04-20

Similar Documents

Publication Publication Date Title
BR0313546A (pt) Uso de acetato de anacortave para a proteção de acuidade visual em pacientes com degeneração macular relacionada com a idade
TW200503674A (en) Therapeutic agents
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
WO2008037380A3 (de) Alkylbenzoat gemische
GB0421639D0 (en) Methods and compositions relating to alzheimer's disease
MXPA04004842A (es) Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1.
MXPA04004837A (es) Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1.
DE602004017252D1 (de) Körperlichepflegemittel Zusammensetzungen enthaltend strukturierte Pflegemittel-Vormischung
MXPA02011632A (es) Inhibidores de 11-beta-hidroxiesteroide deshidrogenasa tipo 1.
BR0318278A (pt) compostos de éter aminocicloexìlico e usos dos mesmo
SI1594833T1 (sl) Derivati 1-fenilalkankarboksilne kisline za zdravljenje nevrodegenerativnih bolezni
BR0311777A (pt) Composição de vesìcula meningocócica multivalente, vacina para o tratamento de doença neisserial, métodos para fabricação de composição de vesìcula meningocócica multivalente e para prevenção ou tratamento de doença neisserial, e, uso de uma quantidade imunologicamente eficaz da vacina
WO2004096216A3 (en) Use of a topical medicament comprising riluzole
BR0210013A (pt) Gel oftálmico de pirenzepina
BR0308713A (pt) Co-esférula de dha e alecrim, e métodos de uso
WO2003015780A8 (en) Isoxazolopyridinones and use thereof in the treatment of parkinson's disease
WO2003020963A3 (en) Proteins in type 2 diabetes
BRPI0407742A (pt) uso de glicocorticóides para preparação de formulação utilizáveis no tratamento de angiogênese ocular patológica, bem como formulção assim obtida
BRPI0516666A (pt) 2-alcóxi-3,4,5-trihidróxi-alquilamidas, o respectivo preparo, composições que as contém e a respectiva utilização
BR0308201A (pt) Derivados de quinolina
TW200504051A (en) Novel acridine derivatives and their use as medicaments
BR0306778A (pt) Derivados de carboxamidina e seu uso no tratamento de doenças vasculares
UY28047A1 (es) Derivados de 7h-dibenzo(b,g)(1,5)dioxocin-5-ona y su uso
ATE261732T1 (de) Pharmazeutische zusammensetzung, umfassend eukalyptus- und orangenöl
BR0206087A (pt) Formulação de enxaguamento redutora para uso com ozÈnio no tratamento de cáries dentárias

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8AANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011.